Abstract
The actual aetiology of Graves’ disease, like that of Hashimoto’s chronic thyroiditis, remains unknown. The condition of hyperthyroidism was initially recognized by Parry in 1786 and recorded cases were published in 18251. Subsequently, Graves, from whom the eponym has been derived, described three cases in greater detail in 18352. Basedow also described the condition in great detail in 18403. It is recognized that females are affected by Graves’ disease much more commonly than males, as is true for virtually all thyroidal disorders, the reported ratios varying from 4:1 to 10:1. The familial occurrence of hyperthyroidism has been recognized by several investigators for many years. Bartels found evidence of a familial disposition in 60% of cases with Graves’ disease4. Pedigrees have been published that have shown a high incidence of Graves’ disease in families; however, a definitive pattern of inheritance has not been established. Although hereditary factors appear to be involved in the pathogenesis of Graves’ disease, it is apparent that a combination of several genetic and environmental determinants are involved rather than a single gene as being a predominant factor. The twin and clinical family studies initially demonstrated the important role of hereditary factors in Graves’ disease. The investigation of autoantibodies and immunogenetic markers have further supported the hereditary importance. Furthermore, the greater rate of concordance of hyperthyroidism among monozygotic twins is also indicative of hereditary determinants in this condition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Parry, C. H. (1825). Collections from Unpublished Medical Writings of the Late Caleb Hillier Parry. Vol. 2, p. 111. (London: Underwoods).
Graves, R. G. (1835). Newly observed affection of the thyroid gland in females. Lond. Med. Surg. J., 7, 516–20.
von Basedow, K. A. (1840). Exophthalmos druch Hypertrophie der Zellgewebes in der Augenhöhle. Wschr. Ges. Heilk14, 197.
Bartels, E. D. (1941). Heredity in Graves’Disease. (Copenhagen: Munksgaard).
Verscheur, O. V. (1958). Die Zwillingsforschung im Dienste der innern Medizin. Verband. Deut. Gesell Inn. Med., 64, 262–73.
Tamai, H., Suematsu, H., Ikemi, Y., Kuma, K., Matsuzuka, F., Kumagai, L. F., Shizume, K. and Nagataki, S. (1978). Responses to TRH and T3 suppression tests in euthyroid subjects with a family history of Graves’ disease. J. Clin. Endocrinol. Met ab., 47,475–9.
Tamai, H., Ohsako, N., Takeno, K., Fukino, O., Takahashi, H., Kuma, K., Kumagai, L. F. and Nagataki, S. (1980). Changes in thyroid function in euthyroid subjects with family history of Graves’disease; a follow-up study of 69 patients. J. Clin. Endocrinol. Metab., 51, 1123–8.
Chopra, I. J., Solomon, D. H., Chopra, U., Yoshihara, E., Teraski, P. L. and Smith, F. (1977). Abnormalities in thyroid function in relatives of patients with Graves’ disease and Hashimoto’s thyroiditis: lack of correlation with inheritance of HLA-B8. J. Clin. Endocrinol. Metab., 45, 45–54.
Ingbar, S. H., Freinkel, N., Dowling, J. T. and Kumagai, L. F. (1965). Abnormalities of iodine metabolism in euthyroid relatives with Graves’ disease, J. Clin. Invest., 35, 714.
Tanaka, T., Katayama, S., Kuma, K., Tamai, T., Matsuzuka, F. and Hidaka, H. (1980). Clinical and pathological significance of sibling Graves’ disease. Acta Endocrinol., 94, 498–502.
Tamai, H., Nakagawa, T., Ohsako, N., Fukino, O., Takahashi, H., Matsuzuka, F., Kuma, K. and Nagataki, S. (1980). Changes in thyroid functions in patients with euthyroid Graves’ disease. J. Clin. Endocrinol. Metab., 50, 108–12.
Banovac, K., Zakarija, M., Mckenzie, J. M., Witte, S. and Sekso, M. (1981). Absence of thyroid stimulating antibody and long acting thyroid stimulator in relatives of Graves’ disease patients. J. Clin. Endocrinol. Metab., 53, 651–3.
Werner, S. C. (1978). Etiology, pathogenesis, immune system, other mechanism, emotional factors. In Werner, S. C. and Ingbar, S. H. (eds.) The Thyroid: A Fundamental and Clinical Text. 4th Edn., p. 616. (New York: Harper and Row).
Kriss, J. P., Pleshakov, V. and Chien, J. R. (1964). Isolation and identification of the long-acting thyroid stimulator and its relation to hyperthyroidism and circumscribed pretibrial myxedema. J. Clin. Endocrinol. Metab., 24, 1005–11.
Bonnyns, M., Vanhaelst, J., Golstein, J., Caunchie, C., Ermans, A. M. and Bastenie, P. A (1973). Long-acting thyroid stimulator and thyroid function in relatives of patients with Graves’disease. Clin. Endocrinol., 2, 211-211 SI.
Kitchin, F. D. and Weinstein, I. B. (1978). Genetic factors in thyroid disease. In Werner, S. C. and Ingbar, S. H. (eds.) The Thyroid: A Fundamental and Clinical Text. 4th Edn., p. 495. (New York: Harper and Row).
Howel-Evans, A. W., Woodrow, J. C. and McDougall, C. D. M. (1967). Antibody in families of thyrotoxic patients. Lancet, 1, 636–41.
Friedman, J. M. and Fialkow, P. J. (1978). The genetics of Graves’ disease. Clin. Endocrinol. Metab., 1, 47–65.
Fialkow, P. J., Thuline, H. C., Hecht, F. and Bryant, J. (1971). Familial predisposition to thyroid disease in Down’s syndrome: controlled immunoclinical studies. Am. J. Hum. Gen., 23, 67–86.
Azizi, F., Chandler, H., Bozorgzadeh, H. and Braverman, L. E. (1974). The occurrence of hyperthyroidism in patients with Down’s syndrome. Hosp. Med. J., 134, 303–6.
Fialkow, P. J. (1970). Thyroid autoimmunity and Down’s syndrome. Ann. N. Y. Acad. Sei., 171,500–11.
Boas, N. F. and Oher, W. B. (1946). Hereditary exophthalmic goitre: report of eleven children in one family. J. Clin. Endocrinol. Metab., 6, 575–82.
Volpe, R., Farid, N. R., Von Westarp, C. and Row, V. V. (1974). The pathogenesis of Graves’disease and Hashimoto’s thyroiditis. Clin. Endocrinol., 3, 239–61.
Volpe, R. (1981). Auto-immunity in thyroid disease. In Volpe, R. (ed.) Monographs on Endocrinology, Auto-immunity in the Endocrine System, p. 108. (New York: Springer-Verlag).
Strakosh, R. D., Wenzel, B. E., Row, V. V. and Volpe, R. (1982). Immunology of autoimmune thyroid disease. N. Engl. J. Med., 307, 1499–507.
McGregor, A. M., Peterson, M. M., Capifferi, R., Evered, D. C., Rees-Smith, B. and Hall, R. (1979). Effects of radioiodine on thyrotropin binding inhibiting immunoglobulin in Graves’disease. Clin. Endocrinol., 11,437–44.
Schleusener, H., Kotulla, P., Finke, R., Sorje, H., Meinhold, H., Adlkofer, F. and Wenzel, K. W. (1978). Relationship between thyroid status and Graves’ disease - specific immunoglobulin. J. Clin. Endocrinol. Me tab., 41, 379–84.
Endo, K., Kasagi, K., Konishi, J., Ikekubo, K., Okuno, T., Takeda, Y., Mori, T. and Torizuka, K. (1978). Detection and properties of TSH binding inhibitor immunoglobulin in patients with Graves’disease and Hashimoto’s thyroiditis. J. Clin. Endocrinol. Metab., 46, 734–9.
Teng, C. S., Yeung, R. T. T., Khoo, R. K. K. and Alagaratnam, T. T. (1980). A prospective study of the changes in thyrotropin binding inhibitory immunoglobulin in Graves’ disease treated by subtotal thyroidectomy or radioactive iodine. J. Clin. Endocrinol. Metab., 50, 1005–10.
Kishihara, M., Nakao, Y., Baba, Y., Kobayashi, N., Matukura, S., Kuma, K. and Fujita, T. (1981). Interaction between thyrotropin (TSH) binding inhibitor immunoglobulin (TBII) and soluble TSH receptors in fat cell. J. Clin. Endocrinol. Metab., 52, 665–70.
Burman, K. D. and Baker, J. R. (1985). Immune mechanisms in Graves’disease. Endocrine Rev., 6, 183–232.
Mukhtar, E. D., Smith, B. R., Pyle, G. A., Hall, R. and Vice, P. (1975). Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drug. Lancet, 1, 713–5.
McGregor, A. M., McLachlan, S. M., Rees-Smith, B. and Hall, R. (1979). Effect of irradiation on thyroid-autoantibody production. Lancet, 2, 442–4.
Zakarija, M., McKenzie, J. M. and Banovac, K. (1980). Clinical significance of assay of thyroid stimulating antibody in Graves’ disease. Ann. Int. Med., 93, 28–32.
Beck, K., Feldt-Rasmussen, U., Bliddal, H., Date, J. and Blickert-Toft, M. (1982). The acute changes in thyroid stimulating immunoglobulin, thyroglobulin and thyroglobulin antibodies following subtotal thyroidectomy. Clin. Endocrinol., 16, 235–42.
Macchia, E., Fenzi, G. F., Monzani, F., Lippi, F., Vitti, P., Grasso, L., Bartalena, L., Baschieri, L. and Pinchera, A. (1981). Comparison between thyroid stimulating and TSH binding inhibiting immunoglobulins of Graves’disease. Clin. Endocrinol., 15, 175–82.
Kuzuya, N., Chiu, S. C., Ikeda, H., Uchimura, H., Ito, K. and Nagataki, S. (1979). Correlation between thyroid stimulators and 3,5,3’-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drug: comparison of assays by thyroid stimulating and thyrotropin displacing activities. J. Clin. Endocrinol. Metab., 48, 706–11.
Karlsson, F. A. and Dahlberg, P. A. (1981). Thyroid stimulating antibody (TSAb) in patients with Graves’ disease undergoing antithyroid drug treatment: indicators of activity of disease. Clin. Endocrinol., 14, 579–85.
Etienne-Decerf, J. and Winand, R. J. (1981). A sensitive technique for determination of thyroid-stimulating immunoglobulin in unfractionated serum. Clin. Endocrinol., 14, 83–91.
Rapoport, B., Greenspan, F. S., Filettr, S. and Pepitone, M. (1984). Clinical experience with a human thyroid cell bioassay for thyroid stimulating immunoglobulin. J. Clin. Endocrinol. Metab., 58, 332–8.
Atkinson, S. and Kendall-Taylor, P. (1981). The stimulation of thyroid hormone secretion in vitro by thyroid-stimulating antibodies. J. Clin. Endocrin. Metab., 53, 1263–6.
Smyth, P. P. A., Neylan, D. and O’Donovan, D. K. (1982). The prevalence of thyroid stimulating antibodies in goitrous disease assessed by cytochemical section bioassay. J. Clin. Endocrinol. Metab., 54, 357–61.
Davis, T. F., Yeo, P. P. B., Evered, D. C., Clark, F., Smith, B. R. and Hall, R. (1977 Value of thyroid stimulating antibody determination in predicting short-term thyrotoxic relapse in Graves’disease. Lancet, 1, 1181–2.
Matsuura, N., Yamada, T., Nohara, Y., Knoishi, J., Kasagi, K., Endo, K., Kojima, H. and Wataya, K. (1980). Familial neonatal transient hypothyroidism due to maternal TSH- binding inhibition immunoglobulin. N. Engl. J. Med., 303, 738–41.
Takasu, N., Mori, T., Koizumi, Y., Takeuchi, S. and Yamada, T. (1984). Transient neonatal hypothyroidism due to maternal immunoglobulin that inhibit thyrotropin-binding and post-receptor processes./Clin. Endocrinol. Metab., 59, 142–146.
Takasu, N., Naka, M., Mori, T. and Yamada, T. (1984). Two types of thyroid function- blocking antibodies in autoimmune atrophic thyroiditis and transient neonatal hypothyroidism due to maternal IgG. Clin. Endocrinol., 21, 345–55.
Konishi, J., Iida, Y., Endo, K., Misaki, T., Nohara, Y., Matsuura, N., Mori, T. and Torizuka, K. (1983). Inhibition of thyrotropin-induced adenosin 3’5’-monophosphate increase by immunoglobulins from patients with primary myxedema. J. Clin. Endocrinol. Metab., 57, 544–9.
Steel, N. R., Weightman, D. R., Taylor, J. J. and Kendall-Taylor, P. (1984). Blocking activity to action of thyroid stimulating hormone in serum from patients with primary hypothyroidism. Br. Med. J., 288, 1559–64.
Frelinger, J. A. and Shreffler, D. C. (1975). The major histocompatibility complex. In Benacerraf, B. (ed.) Immunogenetics and Immunodeficiency, p. 81. (Baltimore: University Park Press).
Bach, F. H. and Van Rood, J. J. (1976). The major histocompatibility complex - genetics and biology. N. Engl. J. Med., 295, 806–13.
Irvine, W. J., Gray, R. J., Moriss, P. J. and Ting, A. (1977). Correlation of HLA and thyroid antibodies with clinical course of thyrotoxicosis treated with antithyroid drugs. Lancet, 2, 898–900.
Bech, K., Lunholtz, B., Nerup, J., Tomsen, M., Platz, P., Ryder, L. E., Svejgaard, A., Siersbock-Nielsen, K., Hanse, J. M., and Larsen, J. H. (1977). HLA antigens in Graves1 disease. Acta Endocrinol., 86, 510–5.
McGregor, A. M., Smith, B. R. and Hall, R. (1980). Prediction of relapse in hyperthyroid Graves’disease. Lancet, 1, 1101–3.
Schleusener, H., Schernthaner, G., Mayr, W. R., Kotulla, P., Bogner, U., Finke, R., Meinhold, H., Koppenhagen, K. and Wenzel, K. W. (1983). HLA-DR3 and HLA-DR5 associated thyrotoxicosis - two different types of toxic diffuse goiter. J. Clin. Endocrinol. Metab., 56, 781–5.
Allannic, H., Fauchet, R., Lorcy, Y., Gueguen, M., Guerrier, A. L. and Genetel, B. (1983). A prospective study of the relationship between relapse of hyperthyroid Graves’ disease after antithyroid drugs and HLA haplotype. J. Clin. Endocrinol. Metab., 57, 719–22.
Wenzel, K. W. and Lente, J. R. (1984). Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulin in Graves’ disease: evidence against an immunosuppressive action of thionamide drugs. J. Clin. Endocrinol. Metab., 58, 62–9.
Weetman, A. P., Gunn, C., Hall, R. and McGregor, A. (1984). Immunosuppression by perchlorate. Lancet, 1, 906.
Grumet, F. C., Payne, R. O., Konishi, J. and Kriss, J. P. (1974). HL-A antigens as markers for disease susceptibility and autoimmunity in Graves’disease. J. Clin. Endocrinol. Metab., 39, 1115–9.
Grumet, F. C., Payne, R. O., Konishi, J., Mori, T. and Kriss, J. P. (1975). HL-A antigens in Japanese patients with Graves’ disease. Tissue Antigen6, 347–52.
Farid, N. R., Barnard, J. M. and Marshall, W. H. (1976). The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves’disease. Tissue Antigen., 8, 181–9.
Beck, K., Lumholtz, B., Nerup, J., Thomsen, M., Platz, P., Ryder, L. P., Svejgaard, A., Siersbck-Nielsen, K., Hansen, J. M. and Larsen, J. H. (1977). HLA antigens in Graves’ disease. Acta Endocrinol., 86, 510–6.
Farid, N. R., Sampson, E. P., Barnard, J. M., Mandeville, R., Lasen, B. and Marshall, W. H. (1979). A study of human leucocyte D locus related antigen in Graves’ disease. J. Clin. Invest., 63, 108–13.
Uno, H., Sasazuki, T., Tamai, H. and Matsumoto, H. (1981). Two major genes linked to HLA and Gm control susceptibility to Graves’ disease. Nature (London), 292, 768–70.
Farid, N. R., Stone, E. and Johnson, G. (1980). Graves’ disease and HLA: clinical and epidemiological associations. Clin. Endocrinol., 13, 535–44.
Schernthaner, G., Schleusner, H., Kotulla, P., Finke, R., Wenzel, B. and Mayr, W. R. (1981). Prediction of relapse or long term remission in hyperthyroid Graves’ disease. Lancet, 2, 323–5.
Sasazuki, T., Kohno, Y., Iwamoto, L. and Tanimura, M. (1977). HLA-B, D, haplotypes associated with autoimmune disease in Japanese populations. Tissue Antigens., 10, 218–24.
Wells, J. V., Fundenberg, H. H. and Mackay, I. R. (1971). Relation of the human antibody response to flagellin to Gm genotypes. J. Immunol., 107, 1505–11.
Shreffler, D. C. and Davis, D. C. (1975). The H-2 major histocompatibility complex and immune response region: genetic variations, function, and organization. Adv. Immunol., 20, 125–9.
Pandy, J. P., Fudenberg, H. H., Virella, G., Kyong, C. U., Loadholt, C. B. and Galbraith, R. M. (1979). Association between immunoglobulin allotypes and immune response to Haemophilus influenzae and Meningococcus polysaccharides. Lancet, 1, 190–2.
Lieberman, K., Potter, M., Humphrey, W., Jr. and Chen, C. C. (1976). Idiotypes of insulin-binding antibodies and myeloma proteins controlled by genes linked to the allotype locus of the mouse. J. Immunol., 117, 2105–11.
Pisetski, D. S., Piodran, S. E. and Sachs, D. H. (1978). Genetic control of the immune response to staphylococcal nuclease. J. Immunol., 122, 842–6.
Nakao, Y., Matsumoto, H., Miyazaki, T., Nishitani, H., Takasuki, K., Katsukawa, R., Nakayama, S., Izumi, S., Fujita, T. and Tsuji, K. (1980). IgG heavy chain allotypes (Gm) in autoimmune disease. Clin. Exp. Immunol., 42, 20–6.
Farid, N. R., Newton, R. M., Noel, E. P. and Marshall, W. H. (1977). Gm phenotype in autoimmune thyroid disease. J. Immunogenet., 4,429–32.
Nakao, Y., Kishihara, M., Baba, Y., Kuma, K., Fukunishi, T. and Imura, H. (1978). HLA antigens in autoimmune thyroid disease. Arch. Intern. Med., 138, 567–70.
Smith, M., Krinsky, A., Arredondo-Vega, F., Wang A. L. and Hirschhorn, K. (1981). Confirmation of the assignment of genes for human immunoglobulin heavy chains to chromosome 14 by analyses of Ig synthesis by man-mouse hybridoma. Eur. J. Immunol., 11, 852–5.
Tamai, H., Uno, H., Hirota, Y., Matsubayashi, S., Kuma, K., Matsumoto, H., Kumagi, L. F., Sasazuki, T. and Nagataki, S. (1985). Immunogenetics of Hashimoto’s and Graves’ disease. J. Clin. Endocrinol. Met ab., 60, 62–5.
Farid, N. R., Barnard, J. M., Marshall, W. H., Woolferey, I. and O’Driscoll, R. F. (1977). Thyroid autoimmune disease in a large Newfoundland family: the influence of HLA. J. Clin. Endocrinol. Me tab., 45, 1165–72.
Adams, D. D., Adams, Y. J., Knight, J. G., McCall, J., White, P., Parkinson, P., Horrocks, R. and Van Loghen, E. (1983). On nature of the genes influencing the prevalence of Graves’ disease. Life Sei., 31, 3–11.
Sasazuki, T., Kohno, Y., Iwamoto, I., Tanimura, M. and Naito, S. (1978). Association between an HLA haplotype and low responsiveness to tetanus toxoid in man. Nature (London), 111, 359–61.
Sasazuki, T., Kaneko, H., Nishimura, Y., Kaneko, R., Hayama, M. and Ohkuni, H. (1980). An HLA-linked immune suppression gene in man. J. Exp. Med., 152, 297–313.
Schwartz, M., Lifshitz, R., Givol, D., Mozes, E. and Haimovich, T. (1978). Cross-reactive idiotypic determinants on murine anti(T.G)-A-L antibodies. J. Immunol., 121,421–426.
Greenberg, L. J., Gray, D. and Yunis, J. E. (1975). Association of HL-A5 and immune responsiveness in vitro to streptococcal antigens. J. Exp. Med., 141, 935–43.
Martin, L. and Fisher, R. A. (1951). The hereditary and familial aspects of toxic nodular goiter (secondary thyrotoxicosis). Q. J. Med., 20, 293–8.
Fräser, G. R. (1963). A genetical study of goiter Ann. Hum. Genet., 26, 335–40.
Saxena, K. M. (1965). Inheritance of thyroglobulin antibody in thyrotoxic children. Lancet, 1, 583–6.
Doniach, D. (1975). Humoral and genetic aspects of thyroid autoimmunity. Clin. Endocrinol. Metab., 4, 267–85.
Farid, N. R., Von Westarp, C., Row, V. V. and Volpe, R. (1974). Studies of cell-mediated immunity (CMI) in relatives of patients with Graves’disease. J. Clin. Endocrinol. Metab., 39, 778–84.
Boas, N. F. and Ober, W. B. (1945). Hereditary exophthalmic goiter - report of eleven cases in one family. J. Clin. Endocrinol. Metab., 6, 575–88.
Sorensen, E. W. (1958). Thyroid diseases in a family. Acta Medica Scandinavia, 162,123–7.
Wilroy, R. S. and Etteldorf, J. N. (1971). Familial hyperthyroidism including two siblings with neonatal Graves’disease. J. Pediatr., 78, 625–32.
Hollingsworth, D. R., McKean, M. E. and Roeckel, I. (1974). Goiter, immunological observations, and thyroid function tests in Down’s syndrome. Am. J. Dis. Child., Ill, 524–7.
Mason, A. M. S., Raper, C. G. and Lloyd, P. (1970). Thyrotoxicosis in a father and two sons. Lancet, 1, 81.
Hollingsworth, D. R., Mabry, C. C. and Eckerd, J. M. (1972). Hereditary aspects of Graves’ disease in infancy and childhood. J. Pediatr., 81,446–59.
Sasazuki, T., Uno, H., Yasuda, H., Tamai, H. and Matsumoto, H. (1982). Evidence for HLA-linked and Gm-linked genes in Graves’disease. In Tamir, B. B. (ed.) Human Genetics, Part B, p. 65. (New York: Liss).
Sasazuki, T., Nishimura, Y., Muto, M. and Ohta, N. (1983). HLA-linked genes controlling immune response and disease susceptibility. Immunol. Rev., 70, 51–75.
Cudworth, A. G. and Woodrow, J. C. (1975). Evidence for HLA-linked genes in ’juvenile’ diabetes mellitus. Br. Med. J., 3, 133–5.
Day, N. E. and Simons, M. J. (1976). Disease susceptibility genes. Their identification by multiple case family studies. Tissue Antigen., 8, 109–19.
Thomson, G. and Bodmer, W. F. (1977). The genetics of HLA and disease association. In Christianess, T. B. and Feachel, T. M. (eds.) Measuring Selection in National Populations. p. 545. (Berlin: Springer-Verlag).
Svejgaard, A. and Ryder, L. P. (1981). HLA genotype distribution and genetic models of insulin-dependent diabetes mellitus. Ann. Hum. Genet., 45, 293–8.
Farid, N. P. and Bear, J. C. (1983). Autoimmune endocrine disorders and the major histocompatibility complex. In Davis, T. (ed.) Autoimmune Endocrine Disease, p. 59. (New York: Wiley and Sons).
Stenszky, V., Kozma, L., Balazs, Cs., Rocheitz, Sz., Bear, J. C. and Farid, N. R. (1985). The genetics of Graves’ disease: HLA and disease susceptibility. J. Clin. Endocrinol. Metab., 61, 735–40.
Farid, N. R. (1981). Graves’disease. In Farid, N. R. (ed.) HLA in Endocrine and Metabolic Disorders, p. 85. (New York: Academic Press).
Chan, S. H., Yeo, P. P. B., Cheah, J. S. and Lim, P. (1980). HLA haplotype sharing in affected siblings in multiple case Chinese families with thyrotoxicosis. Tissue Antigen16, 258–63.
Joassoo, A., Robertson, P. and Murray, I. P. C. (1975). Viral antibodies in thyrotoxicosis. Lancet, 2, 125.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 MTP Press Limited
About this chapter
Cite this chapter
Tamai, H., Kumagai, L.F., Nagataki, S. (1986). Immunogenetics of Graves’ Disease. In: McGregor, A.M. (eds) Immunology of Endocrine Diseases. Immunology and Medicine, vol 3. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4171-7_7
Download citation
DOI: https://doi.org/10.1007/978-94-009-4171-7_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8352-2
Online ISBN: 978-94-009-4171-7
eBook Packages: Springer Book Archive